BC
RVNC

Brookfield Corp’s Revance Therapeutics, Inc. RVNC Stock Holding History

Brookfield Corp’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-58,727
Closed -$1.49M – 553
2023
Q2 		$1.49M Buy
+58,727
New +$1.83M 0.01% 435
2022
Q4 		– Sell
-124,347
Closed -$3.36M – 771
2022
Q3 		$3.36M Sell
124,347
-37,401
-23% -$759K 0.01% 348
2022
Q2 		$2.23M Sell
161,748
-35,375
-18% -$545K 0.01% 393
2022
Q1 		$3.84M Buy
+197,123
New +$2.99M 0.01% 296

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return